Ajanta Pharma Limited has issued a clarification regarding a news article published on January 19, 2026, by Reuters and other publications, which suggested the company might take a stake in Restaurant Brands Asia, the operator of Burger King in India.

The company explicitly stated that neither Ajanta Pharma Limited nor its management is involved in the transaction mentioned in the news article. They clarified that they have not entered into, discussed, negotiated, or considered any proposal related to acquiring a stake in Restaurant Brands Asia or any Burger King franchise entity.

Ajanta Pharma Limited has denied the incorrect reference to the company in the article and refuted any circulating rumors and speculations on social media. The company emphasized its adherence to high standards of corporate governance and committed to promptly communicating any material information requiring disclosure to the stock exchanges.